GlassScriptPhysician profile
Boskey Patel
NPI 1336534429
$19,698.91
in general payments reported to CMS, 2019-2025
37 companies · $2,995 in 2025
The $2,995 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,217 · 2020: $1,292 · 2021: $1,801 · 2022: $6,332 · 2023: $1,527 · 2024: $4,534 · 2025: $2,995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,968 · Travel and Lodging: $3,900 · Education: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,968.03 |
| Travel and Lodging | $3,900.16 |
| Education | $187.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,695.31 | 2021-2025 | Onyx Frontier, Corevalve Evolut R, Symplicity G3 |
| Boston Scientific Corporation | $3,907.92 | 2019-2025 | General - Therapies, Avvigo Guidance System, Rotablator Rotational Atherectomy System Console Kit |
| Penumbra, INC. | $1,903.10 | 2021-2022 | |
| Abbott Laboratories | $888.79 | 2019-2024 | Nc Trek Neo, Amplatzer Talisman |
| Shockwave Medical, INC | $758.65 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $751.48 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $549.35 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $527.14 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $481.32 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $396.15 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $374.89 | 2019-2022 | |
| Inari Medical, INC. | $356.14 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $353.74 | 2019-2024 | Jardiance |
| Biotronik INC. | $327.15 | 2022 | |
| Cardiovascular Systems INC. | $309.56 | 2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $274.72 | 2024-2025 | (Bh4) Igt Devices Undivided, Image Guided Therapy Agito |
| Pfizer INC. | $269.99 | 2019-2022 | |
| Asahi Intecc USA, INC. | $197.91 | 2023 | Asahi Ptca Guide Wire |
| Bayer Healthcare Pharmaceuticals INC. | $159.20 | 2019-2023 | |
| Chiesi USA, INC. | $146.24 | 2022-2025 | Kengreal |
| Medtronic Vascular, INC. | $139.15 | 2019-2020 | |
| Amarin Pharma, INC. | $137.69 | 2020-2021 | |
| Abiomed | $129.58 | 2020-2025 | |
| Angiodynamics, INC. | $98.29 | 2023 | Alphavac |
| Astellas Pharma US INC | $97.41 | 2019-2020 | |
| Vifor Pharma, INC. | $87.26 | 2019 | |
| Alexion Pharmaceuticals, INC. | $81.33 | 2021 | |
| Edwards Lifesciences Corporation | $54.60 | 2024-2025 | |
| Z-Medica, LLC | $44.04 | 2020 | |
| Sanofi-Aventis U.S. LLC | $43.17 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $42.36 | 2019-2020 | |
| Zoll Circulation INC | $25.11 | 2025 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Novo Nordisk INC | $21.80 | 2024 | Wegovy |
| Ge Healthcare | $20.41 | 2021 | |
| Terumo Medical Corporation | $18.25 | 2024 | Glidesheath Slender |
| Biomerieux INC | $15.02 | 2023 | |
| Lantheus Medical Imaging, INC. | $14.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boskey Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.